Alzheimer’s disease has become a serious challenge affecting the lives of many people. However, recent research is opening new therapeutic avenues. In this article, we provide an accessible explanation of the latest study on the VCAM1–ApoE pathway published in Nature Aging, along with tools for analyzing protein interactions.
What Is Alzheimer’s Disease:
A basic overview of Alzheimer’s disease:
Alzheimer’s disease is a progressive disorder of the central nervous system and the most common cause of cognitive decline. The disease develops as the nerve cells of the brain gradually die. An early symptom of Alzheimer’s disease is the loss of short-term memory, but as the disease progresses, language ability, judgment, long-term memory, and the ability to perform daily activities all decline.
Clumps of a protein called amyloid β, and abnormal connections inside nerve cells caused by tau protein, are the characteristic changes seen in the Alzheimer’s brain. These changes cause the decline and death of nerve cells, leading to cognitive decline.
Current treatments and their challenges:
Treatment of Alzheimer’s disease aims to slow the progression of symptoms, but at present there is no therapy that completely cures the disease. The main drugs used include acetylcholinesterase inhibitors and NMDA receptor antagonists. These drugs temporarily slow cognitive decline by adjusting the balance of neurotransmitters in the brain.
However, these drugs alleviate symptoms; they do not treat the fundamental cause of the disease. There are also concerns about their long-term effects and side effects. Recent research is advancing new therapies that prevent the accumulation of amyloid β and the development of drugs with neuroprotective effects, but clinically established treatments remain few at present.
Discovery of the VCAM1–ApoE Pathway:
Overview of the study in Nature Aging:
A study published in Nature Aging revealed a new pathway involved in the progression of Alzheimer’s disease (AD): the VCAM1–ApoE pathway. The study showed that microglia (immune cells in the brain) regulate the clearance of neurotoxic damage-associated molecular patterns (DAMPs). The mechanism of DAMP clearance by microglia is controlled by a stepwise process in which microglia migrate toward DAMPs and then carry out phagocytic clearance.
The impact of the VCAM1–ApoE pathway on Alzheimer’s disease:
Induction of VCAM1 has been shown to enhance the chemotaxis of microglia toward Aβ (amyloid β) and the subsequent clearance of Aβ. Specifically, after stimulation with a substance called IL-33, microglia acquire a chemotactic state in which they migrate toward Aβ, and then transition to a state of Aβ phagocytosis. In this process, VCAM1 senses ApoE within Aβ plaques and regulates the chemotaxis of microglia toward Aβ plaques.
The new therapeutic possibilities this pathway offers:
The discovery of the VCAM1–ApoE pathway provides a new approach to treating Alzheimer’s disease. By activating this pathway, the response of microglia to Aβ may be enhanced, potentially reducing the accumulation of Aβ. This raises hopes for the development of therapies that slow or even reverse the progression of Alzheimer’s disease. Furthermore, elucidating the detailed mechanism of this pathway will also help identify new therapeutic targets.
Tools for Analyzing Protein Interactions:
In the paper above, STRINGdb was used to investigate the functional relationships between proteins. I looked a little into how it differs from the commonly used IPA.
Overview of Ingenuity Pathway Analysis (IPA) and STRINGdb
- Ingenuity Pathway Analysis (IPA):
IPA is a tool provided by QIAGEN for analyzing and interpreting ‘omics data. It is based on a large, manually curated knowledge base and supports the analysis of diverse data types such as RNA-seq, proteomics, and metabolomics. - STRINGdb:
STRINGdb is a database specialized in protein–protein interactions that provides extensive interaction information across many species. It also provides scores indicating the reliability of interactions, allowing users to easily identify highly reliable interactions.
How These Tools Help Research:
- IPA:
IPA can perform comprehensive analysis of ‘omics data. It has the ability to predict upstream regulators and downstream effects, which helps in understanding the causes and consequences of specific biological changes. It is also used to identify how changes in genes or proteins are related to specific diseases or biological functions. - STRINGdb:
STRINGdb is extremely useful when building protein–protein interaction networks. These networks are used to understand biological processes and signaling pathways. It also has a function for integrating public datasets, allowing users to analyze interactions using these datasets.
Key Points for Choosing Between Them and Their Respective Features:
-
IPA:
- Features: Comprehensive analysis of ‘omics data, prediction of causal relationships, and analysis of associations with diseases and biological functions.
- When to use: Suitable when comprehensive analysis and interpretation of ‘omics data is needed, or when investigating associations with diseases or biological functions.
-
STRINGdb:
- Features: Specialization in protein–protein interactions, provision of confidence scores, and integration of public datasets.
- When to use: Suitable when information focused on protein–protein interactions is needed, or when the goal is building interaction networks and evaluating their reliability.
Summary:
The Importance of the VCAM1–ApoE Pathway and Future Prospects:
Alzheimer’s disease is the leading cause of dementia, which is increasing worldwide. Among these developments, the discovery of the VCAM1–ApoE pathway points to a new direction for understanding the pathology of Alzheimer’s disease and developing treatments.
Importance:
The VCAM1–ApoE pathway is involved in the mechanism by which microglia recognize the accumulation of amyloid β (Aβ) and effectively clear it. Activation of this pathway suggests the possibility of reducing Aβ accumulation and delaying the progression of Alzheimer’s disease.
Future prospects:
Elucidating the detailed mechanism of the VCAM1–ApoE pathway will lead to the identification of new therapeutic targets. Moreover, as the development of drugs and therapies that activate this pathway advances, new treatment options for Alzheimer’s disease may emerge.
The Evolution of Protein Interaction Analysis Tools and Its Significance:
In recent years, life science research has progressed rapidly, and within it, the analysis of protein interactions plays a central role. Behind this lies the significant contribution of the evolution of analysis tools.
Evolution:
Early protein interaction analysis tools were primarily aimed at providing simple interaction information. However, modern tools have a wide range of functions, including the analysis of ‘omics data, the prediction of causal relationships, and the analysis of associations with disease. Advanced tools such as Ingenuity Pathway Analysis (IPA) and STRINGdb combine large databases with advanced algorithms to enable more sophisticated analysis.
Significance:
The evolution of protein interaction analysis tools has enabled researchers to gain a deeper understanding of biological processes and disease mechanisms. This is accelerating the identification of new therapeutic targets and the development of early diagnosis and treatment methods for diseases. These tools also make it possible to view complex life phenomena from a systems biology perspective, pioneering a new frontier in the life sciences.